These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28761687)

  • 21. Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis.
    Gualtierotti R; Ingegnoli F; Two R; Meroni PL; Khanna D; Adorni G; Becciolini A; Ciavarella T; Marfia G; Murgo A; Scalone L; Ughi N; Zeni S;
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S55-60. PubMed ID: 26339890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society.
    Taş YM; Derviş Hakim G; Keskinoğlu P; Kenar G; Yarkan H; Zengin B; Can G; Önen F; Akkoç N; Birlik M; Akarsu M
    Turk J Gastroenterol; 2019 Mar; 30(3):234-241. PubMed ID: 30541712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
    Stamm L; Garaiman A; Becker MO; Bruni C; Dobrota R; Elhai M; Ismail S; Jordan S; Zampatti N; Tatu AM; Distler O; Mihai C
    RMD Open; 2024 Jul; 10(3):. PubMed ID: 39053950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on the Gastrointestinal Microbiome in Systemic Sclerosis.
    Bellocchi C; Volkmann ER
    Curr Rheumatol Rep; 2018 Jun; 20(8):49. PubMed ID: 29943234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of French version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
    Bae S; Allanore Y; Coustet B; Maranian P; Khanna D
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S15-21. PubMed ID: 21586213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials Consortium.
    McMahan ZH; Frech T; Berrocal V; Lim D; Bruni C; Matucci-Cerinic M; Smith V; Melsens K; Proudman S; Zhang J; Mendoza F; Woods M; Khanna D
    J Rheumatol; 2019 Jan; 46(1):78-84. PubMed ID: 30442827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention.
    Frech TM; Khanna D; Maranian P; Frech EJ; Sawitzke AD; Murtaugh MA
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S22-5. PubMed ID: 21586214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
    Ferreira PL; Genrinho I; Santiago T; Carones A; Mazeda C; Barcelos A; Beirão T; Costa F; Santos I; Couto M; Rato M; Terroso G; Monteiro P
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose naltrexone for pruritus in systemic sclerosis.
    Frech T; Novak K; Revelo MP; Murtaugh M; Markewitz B; Hatton N; Scholand MB; Frech E; Markewitz D; Sawitzke AD
    Int J Rheumatol; 2011; 2011():804296. PubMed ID: 21918649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial.
    Marighela TF; Arismendi MI; Marvulle V; Brunialti MKC; Salomão R; Kayser C
    Rheumatology (Oxford); 2019 Nov; 58(11):1985-1990. PubMed ID: 31056685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study.
    Frech T; Hays RD; Maranian P; Clements PJ; Furst DE; Khanna D
    Rheumatology (Oxford); 2011 Jul; 50(7):1280-7. PubMed ID: 21324979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of Hebrew version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0.
    Ozeri D; Peretz S; Oppenheim A; Watad A; Lidar M; Braun-Moscovici Y
    J Scleroderma Relat Disord; 2023 Feb; 8(1):31-35. PubMed ID: 36743811
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Marchesseau S; Ng SA; Wang YT; Xie W; Ng DC; Totman JJ; Low AHL
    Eur J Radiol; 2018 Aug; 105():289-295. PubMed ID: 30017295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.
    Patrone V; Puglisi E; Cardinali M; Schnitzler TS; Svegliati S; Festa A; Gabrielli A; Morelli L
    Sci Rep; 2017 Nov; 7(1):14874. PubMed ID: 29093509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of gastrointestinal symptoms over time in patients with systemic sclerosis.
    Bering J; Griffing WL; Crowell M; Umar SB
    Rheumatol Int; 2021 Jul; 41(7):1281-1287. PubMed ID: 33630144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic Sclerosis.
    Ross L; Proudman S; Walker J; Stevens W; Ferdowsi N; Quinlivan A; Morrisroe K; Baron M; Nikpour M
    J Rheumatol; 2023 Apr; 50(4):519-525. PubMed ID: 36379565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis.
    Russo E; Bellando-Randone S; Carboni D; Fioretto BS; Romano E; Baldi S; El Aoufy K; Ramazzotti M; Rosa I; Lepri G; Di Gloria L; Pallecchi M; Bruni C; Melchiorre D; Guiducci S; Manetti M; Bartolucci GL; Matucci-Cerinic M; Amedei A
    Rheumatology (Oxford); 2024 Jan; 63(1):226-234. PubMed ID: 37154625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring response in the gastrointestinal tract in systemic sclerosis.
    Khanna D; Nagaraja V; Gladue H; Chey W; Pimentel M; Frech T
    Curr Opin Rheumatol; 2013 Nov; 25(6):700-6. PubMed ID: 24047604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the -174 C/G polymorphism in the interleukin-6 (IL-6) gene and gastrointestinal involvement in patients with systemic sclerosis.
    Zekovic A; Vreca M; Spasovski V; Andjelkovic M; Pavlovic S; Damjanov N
    Clin Rheumatol; 2018 Sep; 37(9):2447-2454. PubMed ID: 29948346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument.
    Khanna D; Hays RD; Park GS; Braun-Moscovici Y; Mayes MD; McNearney TA; Hsu V; Clements PJ; Furst DE
    Arthritis Rheum; 2007 Oct; 57(7):1280-6. PubMed ID: 17907224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.